Costs of Implementing Quality in Research Practice

Meagan Littrell, Stoeger, Maier, Fuchs, Hrabě de Angelis, Cassis, Gerhardt, Grondin, Gailus-Durner (2020) Costs of Implementing Quality in Research Practice Handb Exp Pharmacol (IF: -1) 257 399-423

Abstract

Using standardized guidelines in preclinical research has received increased interest in light of recent concerns about transparency in data reporting and apparent variation in data quality, as evidenced by irreproducibility of results. Although the costs associated with supporting quality through a quality management system are often obvious line items in laboratory budgets, the treatment of the costs associated with quality failure is often overlooked and difficult to quantify. Thus, general estimations of quality costs can be misleading and inaccurate, effectively undervaluing costs recovered by reducing quality defects. Here, we provide examples of quality costs in preclinical research and describe how we have addressed misconceptions of quality management implementation as only marginally beneficial and/or unduly burdensome. We provide two examples of implementing a quality management system (QMS) in preclinical experimental (animal) research environments - one in Europe, the German Mouse Clinic, having established ISO 9001 and the other in the United States, the University of Kentucky (UK), having established Good Laboratory Practice-compliant infrastructure. We present a summary of benefits to having an effective QMS, as may be useful in guiding discussions with funders or administrators to promote interest and investment in a QMS, which ultimately supports shared, mutually beneficial outcomes.

Links

http://www.ncbi.nlm.nih.gov/pubmed/31541322
http://dx.doi.org/10.1007/164_2019_294

Similar articles

Tools